US Broker Ratings

BrightSpring Health Services (BTSG) Investor Outlook: 34% Potential Upside and Strong Buy Ratings Drive Investor Interest

BrightSpring Health Services, Inc. (BTSG), a notable player in the Health Information Services industry, is garnering attention with a striking potential upside of 34.41% and unanimous..

Guardant Health, Inc. (GH) Stock Analysis: 24% Upside Potential Amid Strong Buy Ratings

Guardant Health, Inc. (NASDAQ: GH), a leading player in the diagnostics and research industry, stands at the forefront of precision oncology with its innovative blood and..

The Ensign Group, Inc. (ENSG) Stock Analysis: A 26% Upside Potential in the Healthcare Sector

The Ensign Group, Inc. (NASDAQ: ENSG), a prominent player in the healthcare sector, is gaining attention for its promising growth prospects and solid performance metrics. With..

Alkermes plc (ALKS) Stock Analysis: Exploring a 21.82% Potential Upside

Alkermes plc (NASDAQ: ALKS), a prominent player in the specialty and generic drug manufacturing sector, is drawing significant investor attention with its potential upside of 21.82%...

HealthEquity, Inc. (HQY) Stock Analysis: A Compelling 23.62% Upside Potential

HealthEquity, Inc. (NASDAQ: HQY), a leader in the Health Information Services industry, stands out as an intriguing investment opportunity for those eyeing the healthcare sector. With..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: Riding the Wave of a 141% Potential Upside

Atrium Therapeutics, Inc. (NASDAQ: RNA) has recently captured the attention of investors with a staggering potential upside of 141.31%, according to consensus analyst ratings. This San..

Charles River Laboratories Inte (CRL) Stock Analysis: Navigating the Healthcare Sector with Strategic Partnerships

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a pivotal player within the healthcare sector, specifically in the diagnostics and research industry. With a market..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unveiling a 50.60% Upside Potential

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is making waves in the biotechnology sector with a market capitalization of $14.16 billion. Operating at the intersection of healthcare and..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring an 11.12% Potential Upside in the Healthcare Sector

Henry Schein, Inc. (NASDAQ: HSIC), a juggernaut in the medical distribution industry, is captivating the attention of investors with its solid performance metrics and an enticing..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring an 83% Potential Upside in the Biotechnology Sector

Vaxcyte, Inc. (NASDAQ: PCVX) is making waves in the biotechnology sector with its promising pipeline of vaccine candidates aimed at tackling bacterial infectious diseases. With a..

Solventum Corporation (SOLV) Stock Analysis: Navigating a 7.40% Upside in the Medical Instruments Sector

Solventum Corporation (NASDAQ: SOLV), a burgeoning leader in the healthcare industry, has carved a niche in the medical instruments and supplies sector. With a market capitalization..

Option Care Health, Inc. (OPCH) Stock Analysis: Exploring a 21.73% Upside Potential in the Healthcare Sector

Option Care Health, Inc. (NASDAQ: OPCH), a prominent player in the U.S. healthcare sector, offers a compelling investment opportunity with its diverse range of infusion services...

Glaukos Corporation (GKOS) Investor Outlook: A Promising 17.88% Upside Potential in the Medical Device Sector

In the dynamic landscape of medical technology, Glaukos Corporation (NYSE: GKOS) stands out as a key player in developing innovative therapies for eye disorders. With a..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a Potential 65% Upside in the Biotech Sector

Summit Therapeutics Inc. (NASDAQ: SMMT), a prominent player in the biotechnology industry, is capturing the attention of investors with its promising pipeline and potential for significant..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a Challenging Landscape with a 16.96% Potential Downside

Moderna, Inc. (NASDAQ: MRNA) stands at a pivotal juncture as it navigates the complexities of the biotechnology landscape. Known for its groundbreaking work in messenger RNA..

Insmed Incorporated (INSM) Stock Analysis: A Closer Look at the 54.69% Potential Upside

Insmed Incorporated (NASDAQ: INSM), a prominent player in the biotechnology sector, is making waves in the healthcare industry with its cutting-edge therapies aimed at serious and..

Genmab A/S (GMAB) Stock Analysis: Exploring a 19.69% Potential Upside for the Biotechnology Innovator

Genmab A/S (GMAB), a leading biotechnology firm based in Denmark, has garnered attention among investors for its innovative developments in antibody-based therapies targeting cancer and other..

Nuvalent, Inc. (NUVL) Stock Analysis: Unlocking the Potential of Innovative Cancer Therapies

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company, is carving out a niche in the biotechnology sector with its focus on developing novel therapies for cancer..

Fresenius Medical Care AG (FMS) Stock Analysis: Navigating a 14.82% Potential Upside in the Healthcare Sector

Fresenius Medical Care AG (NYSE: FMS), a significant player in the healthcare sector, stands at the forefront of providing dialysis and related services globally. Headquartered in..

Axsome Therapeutics, Inc. (AXSM) Investor Outlook: A Biotech Stock with 29% Upside and Robust Growth Potential

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is capturing the attention of investors with its remarkable growth trajectory and promising pipeline in the biotechnology sector. Specializing in the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds